Key Takeaways:Peachy is a multiunit beauty aesthetic services brand reimagining aesthetics with a focus on preventative skincare, accessibility, clinical integrity, and consistency.The business grew 60% last year and expanded from 12 to 15 studios.The investment will be used for location expansion, brand development, and talent recruitment.Private equity firm Stride Consumer Partners took a minority stake in aesthetic services brand Peachy.WHO: Launched in 2019 by Dr. Carolyn Treasure and Eric Zhang, Peachy redefined the consumer experience of neuromodulator injections by building a specialized beauty services business that provides an exceptional experience, consistent results, and clinical safety at an accessible and transparent price. Peachy’s expertly administered treatments are delivered by board-certified nurse practitioners in beautifully designed, conveniently located studios. The company currently operates 15 locations across six cities: New York, Chicago, Washington, DC, Atlanta, Austin, and Charlotte.WHY: The fresh capital will fuel investment within key areas of Peachy’s business, including location expansion, brand development, and talent recruitment, to support Peachy’s mission to become the most trusted neuromodulator studio brand in the country.IN THEIR OWN WORDS: “When we launched Peachy, we did so with the intention of creating a radically better experience to make preventative and corrective wrinkle care more approachable,” said Dr. Carolyn Treasure, co-founder and CEO, Peachy.